United States Ninth Circuit

Defendant's bank and securities fraud sentence is vacated where, although the Dura Pharmaceuticals loss causation standard did not apply to criminal securities fraud, the district court applied an erroneous standard of proof in determining total loss for sentencing enhancement purposes.

Appellate Information

• Argued 06/01/2009
• Decided 11/30/2009
• Published 11/30/2009

Judges

• MILAN D. SMITH, JR., Circuit Judge:, Before:  W. FLETCHER, RICHARD R. CLIFTON, and MILAN D. SMITH, JR., Circuit Judges.

Court

• United States Ninth Circuit

Counsel

• For Appellees:
  
• Paul J. Watford, Jacob S. Kreilkamp, and Alexandra Lang Susman, Munger, Tolles & Olson LLP, Los Angeles, CA, for defendant-appellant Richard I. Berger., Christine C. Ewell and Tamra Phipps, Assistant United States Attorneys, United States Attorneys Office for the Central District of California, Los Angeles, CA, for plaintiff-appellee United States of America.